More on: 'COVID-19 coagulopathy in Caucasian patients'.
作者信息
Marietta Marco, Coluccio Valeria, Luppi Mario
机构信息
Hematology Unit, Azienda Ospedaliero-Universitaria, Modena, Italy.
Section of Hematology, Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, Modena, Italy.
出版信息
Br J Haematol. 2020 Jun;189(6):1059-1060. doi: 10.1111/bjh.16772. Epub 2020 May 22.
Abstract
摘要
相似文献
1
More on: 'COVID-19 coagulopathy in Caucasian patients'.更多关于：“白种人患者的新冠病毒感染相关凝血功能障碍”。
Br J Haematol. 2020 Jun;189(6):1059-1060. doi: 10.1111/bjh.16772. Epub 2020 May 22.
2
COVID-19 Coagulopathy: Considerations for Urologists.新型冠状病毒肺炎凝血功能障碍：泌尿外科医生的考量
J Urol. 2020 Oct;204(4):640-641. doi: 10.1097/JU.0000000000001144. Epub 2020 May 18.
3
Sars-CoV-2 Induced Coagulopathy and Prognosis in Hospitalized Patients: A Snapshot from Italy.新型冠状病毒肺炎住院患者中严重急性呼吸综合征冠状病毒2诱导的凝血病与预后：来自意大利的一则简讯
Thromb Haemost. 2020 Aug;120(8):1233-1236. doi: 10.1055/s-0040-1712918. Epub 2020 May 26.
4
The tug-of-war between coagulopathy and anticoagulant agents in patients with COVID-19.新型冠状病毒肺炎患者凝血功能障碍与抗凝药物之间的较量。
Eur Heart J Cardiovasc Pharmacother. 2020 Jul 1;6(4):262-264. doi: 10.1093/ehjcvp/pvaa048.
5
Could antiphospholipid antibodies contribute to coagulopathy in COVID-19?抗磷脂抗体是否会导致新冠病毒病中的凝血病？
J Am Acad Dermatol. 2020 Sep;83(3):e249. doi: 10.1016/j.jaad.2020.06.003. Epub 2020 Jun 4.
6
Can Ticagrelor be used to prevent sepsis-induced coagulopathy in COVID-19?替格瑞洛能否用于预防新型冠状病毒肺炎（COVID-19）中的脓毒症诱导的凝血病？
Clin Immunol. 2020 Jul;216:108468. doi: 10.1016/j.clim.2020.108468. Epub 2020 May 21.
7
Evaluation of SARS-CoV-2 in the female reproductive tract of COVID-19 patients: A prospective study.新冠病毒肺炎患者女性生殖道中严重急性呼吸综合征冠状病毒2的评估：一项前瞻性研究。
J Biol Regul Homeost Agents. 2020;34(5):1885-1888. doi: 10.23812/20-352-L.
8
Telemedicine and e-Health Solutions for COVID-19: Patients' Perspective.针对新冠肺炎的远程医疗和电子健康解决方案：患者视角
Telemed J E Health. 2020 Jul;26(7):847-849. doi: 10.1089/tmj.2020.0099. Epub 2020 Apr 24.
9
The Impact of COVID-19 on Italy: A Lesson for the Future.新冠疫情对意大利的影响：未来之鉴。
Int J Occup Environ Med. 2020 Jul 10;11(3):151-152. doi: 10.34172/ijoem.2020.1984. Epub 2020 Mar 30.
10
[Analysis of coronavirus disease-19 (COVID-19) based on SARS autopsy].基于严重急性呼吸综合征（SARS）尸检的新型冠状病毒肺炎（COVID-19）分析
Zhonghua Bing Li Xue Za Zhi. 2020 Apr 8;49(4):291-293. doi: 10.3760/cma.j.cn112151-20200211-00114.
引用本文的文献
1
Associations between Coronavirus and Immune Response, Cardiorespiratory Fitness Rehabilitation and Physical Activity: A Brief Report.冠状病毒与免疫反应、心肺功能康复和体力活动的关联：简要报告。
Int J Environ Res Public Health. 2023 Mar 6;20(5):4651. doi: 10.3390/ijerph20054651.
2
Massive Arterial Cerebral Thrombosis in a 59-year old Female Patient With Severe COVID-19.一名患有重症新型冠状病毒肺炎的59岁女性患者发生大面积动脉性脑血栓形成。
Cureus. 2021 Jun 9;13(6):e15553. doi: 10.7759/cureus.15553. eCollection 2021 Jun.
3
Anti-inflammatory and antiviral roles of hydrogen sulfide: Rationale for considering H S donors in COVID-19 therapy.硫化氢的抗炎和抗病毒作用：考虑将 H₂S 供体用于 COVID-19 治疗的依据。
Br J Pharmacol. 2020 Nov;177(21):4931-4941. doi: 10.1111/bph.15230. Epub 2020 Aug 26.
4
PARP-inhibitors in a non-oncological indication as COVID-19: Are we aware about its potential role as anti-thrombotic drugs? The discussion is open.PARP 抑制剂在非肿瘤适应证中的应用：我们是否意识到其作为抗血栓药物的潜在作用？这个问题有待讨论。
Biomed Pharmacother. 2020 Oct;130:110536. doi: 10.1016/j.biopha.2020.110536. Epub 2020 Jul 17.
5
More on COVID-19 coagulopathy in Caucasian patients.关于白种人患者的新型冠状病毒肺炎凝血病的更多信息。
Br J Haematol. 2020 Jun;189(6):1060-1061. doi: 10.1111/bjh.16791. Epub 2020 May 25.
本文引用的文献
1
ISTH interim guidance on recognition and management of coagulopathy in COVID-19.国际血栓与止血学会（ISTH）关于新冠病毒病（COVID-19）凝血病识别与管理的临时指南。
J Thromb Haemost. 2020 May;18(5):1023-1026. doi: 10.1111/jth.14810. Epub 2020 Apr 27.
2
COVID19 coagulopathy in Caucasian patients.COVID19 凝血障碍与高加索人群。
Br J Haematol. 2020 Jun;189(6):1044-1049. doi: 10.1111/bjh.16749. Epub 2020 May 17.
3
Hypercoagulability of COVID-19 patients in intensive care unit: A report of thromboelastography findings and other parameters of hemostasis.新冠肺炎患者 ICU 中的高凝状态：血栓弹力描记图结果和其他止血参数报告。
J Thromb Haemost. 2020 Jul;18(7):1738-1742. doi: 10.1111/jth.14850. Epub 2020 Jun 24.
4
COVID-19 and haemostasis: a position paper from Italian Society on Thrombosis and Haemostasis (SISET).新型冠状病毒肺炎与止血：来自意大利血栓形成与止血协会（SISET）的立场文件。
Blood Transfus. 2020 May;18(3):167-169. doi: 10.2450/2020.0083-20. Epub 2020 Apr 8.
5
Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy.抗凝治疗与伴有凝血功能障碍的严重 2019 冠状病毒病患者的死亡率降低相关。
J Thromb Haemost. 2020 May;18(5):1094-1099. doi: 10.1111/jth.14817. Epub 2020 Apr 27.
6
Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia.异常的凝血参数与新型冠状病毒肺炎患者的预后不良有关。
J Thromb Haemost. 2020 Apr;18(4):844-847. doi: 10.1111/jth.14768. Epub 2020 Mar 13.
7
Diagnosis and management of sepsis-induced coagulopathy and disseminated intravascular coagulation.脓毒症诱导的凝血病和弥散性血管内凝血的诊断与管理
J Thromb Haemost. 2019 Nov;17(11):1989-1994. doi: 10.1111/jth.14578. Epub 2019 Aug 13.
8
The role of heparin in sepsis: much more than just an anticoagulant.肝素在脓毒症中的作用：远不止是一种抗凝剂。
Br J Haematol. 2017 Nov;179(3):389-398. doi: 10.1111/bjh.14885. Epub 2017 Aug 18.
9
Human coronavirus NL63 utilizes heparan sulfate proteoglycans for attachment to target cells.人冠状病毒NL63利用硫酸乙酰肝素蛋白聚糖附着于靶细胞。
J Virol. 2014 Nov;88(22):13221-30. doi: 10.1128/JVI.02078-14. Epub 2014 Sep 3.
Zotero 插件